Implantable glucose sensors for diabetes monitoring

Minimally Invasive Therapy and Allied Technologies

Volumn 13, Issue 2, 2004, Pages 78-86

  Renard, Eric ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Continuous monitoring; Diabetes mellitus; Glucose sensor; Implantable devices; Insulin delivery

Indexed keywords

BIOMATERIAL; GLUCOSE; GLUCOSE OXIDASE;

ARTICLE; BLOOD GLUCOSE MONITORING; CALIBRATION; CAPILLARY BLOOD; COMPUTER ANALYSIS; DEVICE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GLUCOSE BLOOD LEVEL; HUMAN; IMPLANT; INTERMETHOD COMPARISON; IONTOPHORESIS; MICRODIALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; SENSOR;

EID: 2342665686     PISSN: 13645706     EISSN: None     Source Type: Journal    
DOI: 10.1080/13645700410026993     Document Type: Article

References (46)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care 1999;22:1827-31.
4. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 2001;24:1634-9.
5. Van den Berghe G, Wouters P, Weekers F, Verwaest C et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
6. American Diabetes Association. Bedside blood glucose monitoring in hospitals. Diabetes Care 2003; 26(Suppl. 1):S119.
7. Renard E. Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? Diabetes Metab 2003;29:2S54-62.
8. Jaremko J, Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care 1998;21:444-50.
9. Gough D, Armour JC. Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes 1995;44:1005-9.
10. Caduff A, Buschor S, Dewarrat R, Schrepfer T et al. Evaluation of a non-invasive, continuous glucose monitoring system in patients with diabetes: results of a glucose clamp study with hypoglycemic and hyperglycemic excursions. Diabetologia 2003; 46(Suppl. 2): A45, 121.
11. Renard E. Implantable closed loop glucose-sensing and insulin delivery: the future for insulin pump therapy. Curr Opin Pharmacol 2003;2:708-16.
12. Fischer U. Fundamentals of glucose sensors. Diabet Med 1991;8:309-21.
13. Gough DA, Armour JC, Baker DA. Advances and prospects in glucose assay technology. Diabetologia 1997;40 (Suppl. 2):S102-7.
14. Kulcu E, Tamada JA, Reach G, Potts RO et al. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 2003;26:2405-9.
15. Ward WK, Jansen LB, Anderson E, Reach G et al. A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002;17:181-9.
16. Garg SK, Potts RO, Ackerman NR, Fermi SJ et al. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 1999;22: 1708-14.
17. Potts RO, Tamada JA, Tierney MJ. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev 2002;18 (Suppl. 1):S49-53.
18. Pitzer KR, Desai S, Dunn T, Edelman S et al. Detection of hypoglycemia with the GlucoWatch Biographer. Diabetes Care 2001;24:881-5.
19. Mastrototaro JJ. The MiniMed Continuous Glucose Monitoring System. Diabetes Technol Ther 2000; 2 (Suppl. 1):S13-18.
20. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ, Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999;277 (Endocrinol Metab 40):E561-71.
21. Cheyne E, Kerr D. Making 'sense' of diabetes: using a continuous glucose sensor in clinical practice. Diabetes Metab Res Rev 2002;18 (Suppl. 1):S43-8.
22. Melki V, Hanaire-Broutin H. Indication of CGMS (Continuous Glucose Monitoring System) in the functional investigations of adult type 1 diabetic patients. Diabetes Metab 2001;27:618-23.
23. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003;52:2790-4.
24. Metzger M, Leibowitz G, Wainstein J, Glaser B et al. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002;25:1185-91.
25. Monsod TP, Flanagan DE, Rife F, Saenz R et al. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia. Diabetes Care 2002;25:889-93.
26. Guerci B, Floriot M, Böhme P, Durain D et al. Clinical performance of CGMS in type 1 diabetic patients treated by continuous insulin infusion using insulin analogs. Diabetes Care 2003;26:582-9.
27. Heinemann L, Koschinsky T. Continuous glucose monitoring: an overview of today's technologies and their clinical applications. Int J Clin Pract 2002;Suppl: 75-9.
28. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46:183-90.
29. Kaufman FR, Gibson LC, Halvorson M, Carpenter S et al. A pilot study of the continuous glucose monitoring system. Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001;24:2030-4.
30. Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003;26:1153-7.
31. Desouza C, Salazar H, Cheong B, Murgo J et al. Association of hypoglycemia and cardiac ischemia. A study based on continuous monitoring. Diabetes Care 2003;26:1485-9.
32. Kerner W. Implantable glucose sensors: present status and future developments. Exp Clin Endocrinol Diabetes 2001;109 (Suppl. 2):S341-6.
33. Meyerhoff C, Bischof F, Sternberg F, Zier H et al. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia 1992;35:1087-92.
34. Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P. Self-monitoring of blood glucose in type 1 diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 1997;20:64-70.
35. Maran A, Crepaldi C, Tiengo A, Grassi G et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-52.
36. Wientjes KJ, Schoonen AJ. Determination of time delay between blood and interstitial adipose tissue glucose concentration change by microdialysis in healthy volunteers. Int J Artif Organs 2001;24:884-9.
37. Freckmann G, Kalatz B, Pfeiffer B, Hoss U et al. Recent advances in continuous glucose monitoring. Exp Clin Endocrinol Diabetes 2001;109 (Suppl. 2):S347-57.
38. Beyer U, Schafer D, Thomas A, Aulich H et al. Recording of subcutaneous glucose dynamics by a viscometric affinity sensor. Diabetologia 2001;44: 416-23.
39. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000;23:208-14.
40. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular glucose sensor in dogs. Diabetes 1990;39:1519-26.
41. Edelman SV, Bouvet M, Fisher JC, Cefalu W. Glucose sensor in the subcutaneous tissue: continuous data in patients with type 1 diabetes. Diabetes 2002; 51 (Suppl. 2):A12, 48-OR.
42. Renard E, Costalat G, Bringer J. From external to implantable insulin pump, can we close the loop? Diabetes Metab 2002;28 (2 Pt 2):2S19-25.
43. Renard EM, Shah R, Miller M, Kolopp M et al. Sustained safety and accuracy of central IV glucose sensors connected to implanted insulin pumps and short-term closed-loop trials in diabetic patients. Diabetologia 2003;46 (Suppl. 2):A47, 128.
44. Bode BW. Clinical utility of the Continuous Glucose Monitoring System. Diabetes Technol Ther 2000; 2 (Suppl. 1):S35-41.
45. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-503.
46. Choleau C, Dokladal P, Klein JC, Ward WK et al. Prevention of hypoglycemia using risk assessment with a continuous glucose monitoring system. Diabetes 2002;51:3263-73.